PATENT CLAIM ANALYSIS

Application Number: 15959521
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "009321"]

Abstract:
The present invention relates to a microvesicle that is derived from nucleated mammalian cells, which are smaller than the nucleated cells. The microvesicles of the present invention can be used in the delivery of a therapeutic or diagnostic substance to specific tissues or cells, and more particularly, relates to microvesicles derived from monocytes, macrophages, dendritic cells, stem cells or the like, which can be used to deliver specific therapeutic or diagnostic substances for treating and/or diagnosing tissue associated with cancer, diseased blood vessels, inflammation, or the like.

Claim (Index 14):
A method of delivering a therapeutic or diagnostic substance to a target cell or tissue, comprising administering to a subject in need thereof a pharmaceutical or diagnostic composition comprising sub-cell sized, nucleated mammalian cell-derived microvesicles loaded with a therapeutic or diagnostic substance,\n wherein the microvesicles are formed by extrusion of a suspension of nucleated mammalian cells and thereby retaining same membrane topology as that of the nucleated mammalian cells.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 1.76786
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13807843', '13807683', '14635379', '14775382', '12488110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.738093740178843
- 35 USC 102 Novelty (BERT): 0.5325782486273616
- Combined Prediction Score: 0.7175421910236949
- Mean Citation Score: 293.169882
- Max Citation Score: 368.9297
- Similarity Product: 265.036238352859

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test